Acrivon Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SANDS CAPITAL VENTURES, LLC | 02/13/2026 | 2.12 M | $5.12 M | 0.00% | 5.50% |
| CITADEL ADVISORS LLC | 02/17/2026 | 1.64 M | $3.96 B | 6.52% | 4.26% |
| VANGUARD GROUP INC | 01/29/2026 | 698.86 K | $1.68 B | 11.61% | 1.81% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 634.17 K | $1.53 M | 1.73% | 1.64% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 585.07 K | $1.41 M | 83.29% | 1.52% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 581.21 K | $1.40 M | 531.72% | 1.51% |
| MARSHALL WACE, LLP | 02/13/2026 | 496.08 K | $1.20 M | 231.35% | 1.29% |
| UBS GROUP AG | 01/29/2026 | 348.54 K | $839.98 K | -48.99% | 0.90% |
| JANE STREET GROUP, LLC | 02/12/2026 | 342.07 K | $824.39 M | 18.26% | 0.89% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 333.77 K | $804.39 K | 144.52% | 0.87% |
| BLACKROCK, INC. | 02/12/2026 | 205.12 K | $494.35 K | -38.02% | 0.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 198.22 K | $477.89 M | 3.22% | 0.51% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 121.52 K | $292.87 K | -34.39% | 0.32% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 119.42 K | $287.81 M | 504.91% | 0.31% |
| STATE STREET CORP | 02/13/2026 | 67.15 K | $161.82 K | 0.00% | 0.17% |
| MORGAN STANLEY | 02/13/2026 | 46.83 K | $112.86 K | -18.07% | 0.12% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 42.90 K | $103.39 K | 87.34% | 0.11% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 26.16 K | $63.05 K | -74.92% | 0.07% |
| BARCLAYS PLC | 02/13/2026 | 24.40 K | $58.81 K | 22.22% | 0.06% |
| XTX TOPCO LTD | 02/17/2026 | 20.57 K | $49.58 K | -42.78% | 0.05% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 18.36 K | $44.31 K | -6.21% | 0.05% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 17.45 K | $42.05 M | -7.71% | 0.05% |
| JPMORGAN CHASE & CO | 02/11/2026 | 16.86 K | $40.64 K | 868.64% | 0.04% |
| CITIGROUP INC | 02/13/2026 | 14.59 K | $35.17 K | -10.51% | 0.04% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 12.43 K | $29.96 K | 100.00% | 0.03% |
| AAF WEALTH MANAGEMENT, LLC | 02/06/2026 | 10.68 K | $25.73 K | 0.00% | 0.03% |
| MAREX GROUP PLC | 02/12/2026 | 10.00 K | $24.10 K | 100.00% | 0.03% |
| FEDERATED HERMES, INC. | 02/12/2026 | 5.61 K | $13.53 K | 131.33% | 0.01% |
| ROYAL BANK OF CANADA | 02/17/2026 | 1.71 K | $4.00 K | 80.49% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 634 | $1.53 K | -46.68% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/15/2026 | 584 | $1.41 K | 0.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 02/12/2026 | 400 | $964 | 0.00% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 02/06/2026 | 373 | $899 | 0.00% | 0.00% |
| OPTIMA CAPITAL LLC | 01/23/2026 | 278 | $670 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 74 | $178 | 0.00% | 0.00% |
| ALGERT GLOBAL LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| COLONY GROUP, LLC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 01/26/2026 | 0 | $0 | -100.00% | 0.00% |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/29/2026 | 0 | $0 | -100.00% | 0.00% |
| GF FUND MANAGEMENT CO. LTD. | 01/27/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Acrivon Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 44 institutional investors and hedge funds held shares of Acrivon Therapeutics Inc. The most heavily invested institutionals were:
Sands Capital Ventures, LLC: 2.12 M
CITADEL ADVISORS LLC: 1.64 M
VANGUARD GROUP INC: 698,857
RENAISSANCE TECHNOLOGIES LLC: 634,169
TWO SIGMA INVESTMENTS, LP: 585,069
ACADIAN ASSET MANAGEMENT LLC: 581,208
48.26% of Acrivon Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 9.83 M shares in the last 24 months. This purchase volume represents approximately $15.53 M in transactions.